UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
SPARTA SURGICAL CORPORATION
(Exact name of issuer as specified in its charter)
Bernal Corporate Park
7068 Koll Center Parkway, Pleasanton, CA 94566
(Address of principal executive offices)
(510) 417-8812
(Issuer's telephone number)
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:
1. Title of security - $.002 Par Value Common Stock, CUSIP # 846648 50 9
--------------------------------------------------------
2. Number of shares outstanding before the change - 3,846,566
---------------------------
3. Number of shares outstanding after the change - 4,410,926
----------------------------
4. Effective date of the change - Through May 24, 1996
---------------------------------------------
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock for treasury,
etc.) - Preferred Stock Conversions, Dividend Distributions, Warrant Exercise
--------------------------------------------------------------------
Give brief description of transaction - Not Applicable
------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change - Not Applicable
----------------------------------------------------
2. Name after change -
-------------------------------------------------------
3. Effective date of charter amendment changing name -
-----------------------
4. Date of shareholder approval of change, if required -
---------------------
Date: May 28, 1996 /s/ Wm. Samuel Veazey
------------------------ ---------------------------
(Officer's signature & title)
